|
|
||||||||
a Department of Internal Medicine,
b Department of Orthopedics, and
c Department of Dentistry, National Taiwan University Hospital and National Taiwan University, College of Medicine, Taipei, Taiwan;
d Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
Key Words. Mesenchymal stem cells • Bone marrow • CFU-F • Multilineage differentiation • ß1-integrin • Femoral head osteonecrosis
Ching-Chuan Jiang, M.D., Ph.D., Department of Orthopedics, National Taiwan University Hospital. No. 7, Chung-Shan South Road, Taipei, Taiwan (100). Telephone: 886-2-23123456 ext 5273; Fax: 886-2-23939632; e-mail: ccj{at}ccms.ntu.edu.tw
Stem cell-based therapies for degenerative disorders and injuries are promising in the new era. Multipotential mesenchymal stem cells (MSCs) from bone marrow (BM) are on the leading edge because they are easy to expand in culture while maintaining their multilineage potential. In vitro assessment of the chondrogenic and osteogenic potentials of cultured MSCs has been established, and the BM used in those experiments was exclusively from healthy donors via iliac crest aspiration. It is unknown whether human marrow obtained from femurs also contains these multipotential MSCs. We collected marrow from proximal femurs of two patients undergoing total hip replacement surgery for femoral head osteonecrosis and isolated and culture expanded MSCs to about 20 population doublings. These cells were homogeneously positive for ß1-integrin. When pelleted into aggregates and cultured in a medium containing transforming growth factor-ß3 for 14 days, the cells began to express mRNA for aggrecan and collagen type II and to deposit immunoreactive collagen type II and sulfated proteoglycans in the matrix, hallmarks of chondrogenic differentiation. These MSCs could also be differentiated into osteocytic lineage in vitro, as shown by increased expression of alkaline phosphatase activity and deposition of mineral content onto culture plates. These results indicate that femoral BM obtained during hip surgeries also contained multipotential MSCs. These data imply that direct replacement therapy using MSCs from in situ marrow may be possible in the future and that an MSC bank may be established by using marrow from this approach, bypassing the necessity for iliac marrow aspiration from healthy donors.
This article has been cited by other articles:
![]() |
K. Inoue, S. Noda, N. Ogonuki, H. Miki, S. Inoue, K. Katayama, K. Mekada, H. Miyoshi, and A. Ogura Differential Developmental Ability of Embryos Cloned from Tissue-Specific Stem Cells Stem Cells, May 1, 2007; 25(5): 1279 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cui, Y. Wang, K. J. Saleh, G.-J. Wang, and G. Balian Alcohol-Induced Adipogenesis in a Cloned Bone-Marrow Stem Cell J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 148 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arnhold, P. Heiduschka, H. Klein, Y. Absenger, S. Basnaoglu, F. Kreppel, S. Henke-Fahle, S. Kochanek, K.-U. Bartz-Schmidt, K. Addicks, et al. Adenovirally Transduced Bone Marrow Stromal Cells Differentiate into Pigment Epithelial Cells and Induce Rescue Effects in RCS Rats. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4121 - 4129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miura, Y. Miura, H. M. Padilla-Nash, A. A. Molinolo, B. Fu, V. Patel, B.-M. Seo, W. Sonoyama, J. J. Zheng, C. C. Baker, et al. Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation Stem Cells, April 1, 2006; 24(4): 1095 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-j. Liu, L. Prazak, M. Fajardo, S. Yu, N. Tyagi, and P. E. Di Cesare Leukemia/Lymphoma-related Factor, a POZ Domain-containing Transcriptional Repressor, Interacts with Histone Deacetylase-1 and Inhibits Cartilage Oligomeric Matrix Protein Gene Expression and Chondrogenesis J. Biol. Chem., November 5, 2004; 279(45): 47081 - 47091. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-W. D. Leong, F.-T. Chew, and D. W. Hutmacher Isolating Bone Marrow Stem Cells Using Sieve Technology Stem Cells, November 1, 2004; 22(6): 1123 - 1125. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
